Page 12 - SaxoCell Annual Report22/23
P. 12
Vision and objectives
SaxoCell will continue to substantially improve regional networking in Saxony in the field
of cell and gene therapy, integrate further partners and initiatives nationwide - and close
corresponding gaps in the value chains. In this way, synergy potentials are to be raised and
realized.
In addition, the cluster will massively
Long term goals increase the visibility of the activities
of Saxonian and nationwide partners in
the field of cell and gene therapy - both
Development of new ATMPs
& expansion of their existing at the level of research and with regard
areas of application to the R&D activities of industrial
partners. In this way, access to funding
for the players is to be facilitated and
Increasing tolerability and expanded, and structures are to be
efficacy of new ATMPs
created to accelerate clinical trans-
lation (network of clinical players and
cooperation with regulatory author-
Efficient production of ities).
ATMPs through automation
Through these and other activities,
SaxoCell will significantly increase the
Optimal environment for the attractiveness for investments of
development of the CGT national and international companies in
industry in Saxony
the industry and contribute signifi-
cantly to the development and further
Strengthening regional strengthening of an innovative cell and
technology transfer through gene therapy industry in Saxony and
investments & settlements
Germany.
7
